Skip to main content

Table 4 Association of glucose and lipid profile levels and other variables at Burayu Health Center, Addis Ababa, Ethiopia, 2012

From: Antiretroviral treatment associated hyperglycemia and dyslipidemia among HIV infected patients at Burayu Health Center, Addis Ababa, Ethiopia: a cross-sectional comparative study

Variables

Glucose/lipid profile levels

Gluc >110 mg/dl

TG ≥ 150 mg/dl

TC ≥ 200 mg/dl

HDL < 40 mg/dl

LDL ≥ 130 mg/dl

UOR (95% CI)

UOR (95% CI)

UOR (95% CI)

UOR (95% CI)

UOR (95% CI)

Gender (Female)

0.52(0.19-1.43)

0.62(0.36-1.10)

1.18(0.63-2.23)

1.37(0.77-2.45)

1.85(0.77-4.42)

P-value

0.208

0.097

0.608

0.289

0.167

Age ≥35years

1.52(0.56-4.12)

1.23(0.78-2.14)

2.30(1.29-4.10)

1.38(0.83-2.30)

2.57(1.23-5.35)

P-value

0.414

0.329

0.005

0.217

0.012

BMI >21.2

0.94(0.35-2.53)

1.27(0.76-2.11)

2.21(1.24-3.92)

1.78(1.07-2.98)

1.78(0.88-3.60)

P-value

0.908

0.358

0.007

0.028

0.108

CD4 + cells <200/mm3

3.21(1.18-8.73)

1.59(0.88-2.86)

0.82(0.42-1.62)

0.96(0.52-1.75)

0.57(0.23-1.44)

P-value

0.023

0.124

0.570

0.884

0.233

HAART Initiated

1.47(0.54-3.98)

1.96(1.17-3.29)

5.81(3.01-11.2)

2.62(1.55-4.44)

3.89(1.76-8.61)

P-value

0.453

0.01

<0.0001

< 0.0001

0.001

HIV duration ≥20 months

1.12(0.42-2.99)

1.19(0.72-1.98)

1.98(1.11-3.51)

1.37(0.82-2.28)

2.11(1.03-4.35)

P-value

0.828

0.500

0.020

0.231

0.042

TB infection

1.19(0.32-4.33)

1.11(0.56-2.23)

0.80(0.36-1.79)

0.68(0.33-1.42)

2.28(1.00-5.18)

P-value

0.798

0.590

0.590

0.307

0.049

  1. HAART, highly active antiretroviral therapy; Gluc, glucose; UOR, un adjusted odds ratio; CI, confidence interval; BMI, body mass index; TC, total cholesterol; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; TG, triglyceride; p, significance level; TB, tuberculosis.